189 related articles for article (PubMed ID: 29934657)
21. Germline mutation analysis in the CYLD gene in Chinese patients with multiple trichoepitheliomas.
Li ZL; Guan HH; Xiao XM; Hui Y; Jia WX; Yu RX; Chen H; Li CR
Genet Mol Res; 2014 Nov; 13(4):9650-5. PubMed ID: 25501176
[TBL] [Abstract][Full Text] [Related]
22. Vismodegib in basal cell carcinoma.
Amaria RN; Bowles DW; Lewis KD; Jimeno A
Drugs Today (Barc); 2012 Jul; 48(7):459-67. PubMed ID: 22844657
[TBL] [Abstract][Full Text] [Related]
23. Pharmacodynamic study of the oral hedgehog pathway inhibitor, vismodegib, in patients with metastatic castration-resistant prostate cancer.
Maughan BL; Suzman DL; Luber B; Wang H; Glavaris S; Hughes R; Sullivan R; Harb R; Boudadi K; Paller C; Eisenberger M; Demarzo A; Ross A; Antonarakis ES
Cancer Chemother Pharmacol; 2016 Dec; 78(6):1297-1304. PubMed ID: 27826729
[TBL] [Abstract][Full Text] [Related]
24. Clinical, genetic and experimental studies of the Brooke-Spiegler (CYLD) skin tumor syndrome.
Andersson MK; Kölby L; Nilsson JA; Stenman G
J Plast Surg Hand Surg; 2019 Apr; 53(2):71-75. PubMed ID: 30676842
[TBL] [Abstract][Full Text] [Related]
25. Multiple familial trichoepithelioma with a novel mutation of the CYLD gene.
Fujii A; Matsuyama K; Mizutani Y; Kanoh H; Nakano H; Seishima M
J Dermatol; 2017 Sep; 44(9):e228-e229. PubMed ID: 28488373
[No Abstract] [Full Text] [Related]
26. Multiple trichoepitheliomas associated with a novel heterozygous mutation in the CYLD gene as an adjunct to the histopathological diagnosis.
Reuven B; Margarita I; Dov H; Ziad K
Am J Dermatopathol; 2013 Jun; 35(4):445-7. PubMed ID: 23694822
[TBL] [Abstract][Full Text] [Related]
27. Mutation analysis of the CYLD gene in two Chinese families with multiple familial Trichoepithelioma.
Chen M; Liu H; Fu X; Yu Y; Yu G; Liu H; Tian H; Zhou G; Zhang D; Wang G; Zhang F
Australas J Dermatol; 2011 May; 52(2):146-7. PubMed ID: 21605102
[No Abstract] [Full Text] [Related]
28. CYLD mutations underlie Brooke-Spiegler, familial cylindromatosis, and multiple familial trichoepithelioma syndromes.
Young AL; Kellermayer R; Szigeti R; Tészás A; Azmi S; Celebi JT
Clin Genet; 2006 Sep; 70(3):246-9. PubMed ID: 16922728
[TBL] [Abstract][Full Text] [Related]
29. Brooke-Spiegler syndrome tumor spectrum beyond the skin: a patient carrying germline R936X CYLD mutation and a somatic CYLD mutation in Brenner tumor.
Ponti G; Ruini C; Girolomoni G; Pellacani G; Farnetani F; Pastorino L; Ghiorzo P; Witkowski AM; Bianchi-Scarrà G; Tomasi A; Loschi P; Nasti S
Future Oncol; 2014 Feb; 10(3):345-50. PubMed ID: 24559443
[TBL] [Abstract][Full Text] [Related]
30. Marie Unna hereditary hypotrichosis accompanied by multiple familial trichoepithelioma in a Chinese family.
Huang Y; Cai C; Ren L; Cui C; Zhang X; Liu W
J Dermatol; 2019 May; 46(5):413-417. PubMed ID: 30809827
[TBL] [Abstract][Full Text] [Related]
31. Brooke-Spiegler syndrome: report of a case of multiple cylindromas and trichoepitheliomas.
Doherty SD; Barrett TL; Joseph AK
Dermatol Online J; 2008 Jul; 14(7):8. PubMed ID: 18718192
[TBL] [Abstract][Full Text] [Related]
32. [Brooke-Spiegler syndrome: an heterogeneous entity].
Mataix J; Bañuls J; Botella R; Laredo C; Lucas A
Actas Dermosifiliogr; 2006 Dec; 97(10):669-72. PubMed ID: 17173833
[TBL] [Abstract][Full Text] [Related]
33. Anticancer drugs and the regulation of Hedgehog genes GLI1 and PTCH1, a comparative study in nonmelanoma skin cancer cell lines.
Olesen UH; Bojesen S; Gehl J; Haedersdal M
Anticancer Drugs; 2017 Nov; 28(10):1106-1117. PubMed ID: 28799948
[TBL] [Abstract][Full Text] [Related]
34. Emergence of chemoresistance in a metastatic basal cell carcinoma patient after complete response to hedgehog pathway inhibitor vismodegib (GDC-0449).
Meani RE; Lim SW; Chang AL; Kelly JW
Australas J Dermatol; 2014 Aug; 55(3):218-21. PubMed ID: 25117162
[TBL] [Abstract][Full Text] [Related]
35. A novel missense mutation in CYLD in a family with Brooke-Spiegler syndrome.
Hu G; Onder M; Gill M; Aksakal B; Oztas M; Gürer MA; Celebi JT
J Invest Dermatol; 2003 Oct; 121(4):732-4. PubMed ID: 14632188
[TBL] [Abstract][Full Text] [Related]
36. CYLD mutations in familial skin appendage tumours.
Saggar S; Chernoff KA; Lodha S; Horev L; Kohl S; Honjo RS; Brandt HR; Hartmann K; Celebi JT
J Med Genet; 2008 May; 45(5):298-302. PubMed ID: 18234730
[TBL] [Abstract][Full Text] [Related]
37. Identification of a large rearrangement in CYLD as a cause of familial cylindromatosis.
van den Ouweland AM; Elfferich P; Lamping R; van de Graaf R; van Veghel-Plandsoen MM; Franken SM; Houweling AC
Fam Cancer; 2011 Mar; 10(1):127-32. PubMed ID: 20972631
[TBL] [Abstract][Full Text] [Related]
38. Vismodegib: an inhibitor of the Hedgehog signaling pathway in the treatment of basal cell carcinoma.
Proctor AE; Thompson LA; O'Bryant CL
Ann Pharmacother; 2014 Jan; 48(1):99-106. PubMed ID: 24259609
[TBL] [Abstract][Full Text] [Related]
39. Mutations in the CYLD gene in Brooke-Spiegler syndrome, familial cylindromatosis, and multiple familial trichoepithelioma: lack of genotype-phenotype correlation.
Bowen S; Gill M; Lee DA; Fisher G; Geronemus RG; Vazquez ME; Celebi JT
J Invest Dermatol; 2005 May; 124(5):919-20. PubMed ID: 15854031
[TBL] [Abstract][Full Text] [Related]
40. An extremely rare association of multiple familial trichoepitheliomas and hereditary multiple osteochondromas.
Monteiro AF; Saraiva Gil F; Rato M; Osório T; Tavares E
Int J Dermatol; 2018 Dec; 57(12):e157-e159. PubMed ID: 30246361
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
